Geldanamycin (GDM) is a 19-membered macrocyclic lactam and is related to ansamycin antibiotics. GDM binds to heat shock protein 90, inhibiting its chaperone activity.1 GDM and its derivatives have the potential to serve as chemotherapeutic agents in cancer and virus-infected diseases.2 A clear understanding of GDM biosynthesis should help us to create novel GDM analogs with optimal properties by genetic manipulation of its biosynthetic pathway.
The biosynthetic gene cluster of GDM, including a set of type-I polyketide synthase (PKS) genes, a set of post-PKS tailoring genes and a separate set of genes for biosynthesis of 3-amino-5-hydroxybenzoic acid, the starter unit for GDM biosynthesis, had been cloned, sequenced and analyzed from several streptomycetes independently.3, 4, 5 The post-PKS tailoring genes, such as gdmN (encoding the carbamoyltransferase for 7-O-carbamoylation), gdmP (encoding the cytochrome P450 monooxygenase for C-4,5 oxidation) and gdmM (encoding the FAD-binding monooxygenase for C-21 hydroxylation), had been disrupted, respectively, in Streptomyces hygroscopicus 17997, S. hygroscopicus subsp. duamyceticus JCM4427 or other GDM producer(s), to confirm their biological functions in GDM biosynthesis.6, 7, 8 As a result, a brief post-PKS tailoring process of GDM biosynthesis was proposed (Figure 1, thick arrows).6
The gel8 (identical to gdmN) disruption mutant of S. hygroscopicus subsp. duamyceticus JCM4427 produced 4,5-dihydro-7-O-descarbamoyl-7-hydroxygeldanamycin (CT-1-7) as major component.6 The gdmN disruption mutant of S. hygroscopicus 17997 produced, besides CT-1-7, 4,5-dihydro-7-O-descarbamoyl-7-hydroxy-19-O-glycylgeldanamycin (CT-1-1), which is a novel GDM analog.9
To examine whether there are other undiscovered GDM analogs in the gdmN disruption mutant of S. hygroscopicus 17997, a time-course monitoring of its fermentation culture was conducted. The fermentation supernatants at different times (36, 60, 84, 108 h, and so on) were extracted with equal volumes of ethyl acetate (EtOAc). The organic layers were concentrated, then subjected to silica-gel TLC (developed with a mobile phase of EtOAc/CH2Cl2/hexane/methanol, 9:6:6:1, v/v) and then alkaline color reaction for a preliminary discrimination of GDM analogs.10 A weak purple band appeared above the blue band of CT-1-7, which was supposed to be a novel GDM analog (at 84 h, Figure 2).
Compounds corresponding to the weak purple band of alkaline treatment were eluted out with EtOAc from silica-gel TLC. A major peak appeared by HPLC analysis, with its retention time being very close to that of CT-1-7, and its UV spectrum profile similar to that of CT-1-7 and very similar to that of GDM (see Supplementary Figure S1). The peak contained a major compound with a molecular weight of 540.5 Da ([M+Na]+), which is two units less than that of CT-1-7 (542.4 Da, [M+Na]+), as analyzed by liquid chromatography-ESI(+)-MS. Based on these data, we suggested the chemical structure of the major compound as 7-O-descarbamoyl-7-hydroxygeldanamycin (designated as CT-1-7x), with a molecular formula of C28H39O8N1.
CT-1-7x was then purified for structural elucidation. An equal volume of EtOAc was used to extract the fermentation supernatant (about 10 l) of gdmN disruption mutant of S. hygroscopicus 17997 (culture time 84 h), then dried to a crude solid (about 3.042 g) by rotary evaporation at 37 °C. It was then fractionated by silica-gel column chromatography. The pool containing CT-1-7x (eluted by petroleum ether–EtOAc, 75:25, v/v) was dried (30.8 mg) and re-dissolved in methanol for preparative Sephadex LH-20 (ϕ1.8 cm × 150 cm) fractionation, yielding the refined preparation (17.9 mg). The refined preparation was used for preparative HPLC (Shimadzu LC-10ATVp, Shimadzu International Trading (Shanghai) Co., Ltd, Beijing, China; Agilent ZorBax SB-C18, Agilent Technologies Co. Ltd (China), Beijing, China, 5 μm, ϕ9.4 mm × 250 mm, methanol/water, 71:29 (v/v), 1.5 ml min−1), yielding a pure preparation of CT-1-7x (10.7 mg, purity⩾97%). The pure preparation, an amorphous yellow powder, was used for 1H- and 13C-NMR analyses.
The 13C-NMR and DEPT spectra displayed 28 carbon signals, including 7 methyls, 2 methylenes, 11 methines and 8 quaternary carbons. The 13C-NMR of CT-1-7x showed strong similarities to that of CT-1-7 except for C-4,5. The carbon signals of CH2-4 (δC 23.84) and CH2-5 (δC 29.19) in CT-1-7 were absent, while two additional olefinic methyl signals at δC 131.163 and 127.340 emerged in the 13C-NMR of CT-1-7x. The hydrogen signals of CH2-4 (δH 2.24/2.43) and CH2-5 (δH 1.74/1.89) of CT-1-7 disappeared in CT-1-7x, while two additional hydrogen signals of CH- (δH 6.590, 6.075) appeared in the 1H-NMR of CT-1-7x. The two newly appeared olefinic methyl signals (CH-4 and CH-5) in CT-1-7x were also confirmed by the DEPT spectra of CT-1-7x. The NMR chemical shifts were assigned completely for CT-1-7x from HSQC, COSY and HMBC (Table 1). Thus, the chemical structure of CT-1-7x was determined to be the C-4,5 olefinic form of CT-1-7, that is, 7-O-descarbamoyl-7-hydroxygeldanamycin. CT-1-7x shared the same chemical structure as the compound designated as CP 144365,11 whose spectroscopic data and references, if any, were not disclosed.
Shin et al.7 proved that a cytochrome P450 monooxygenase encoded by gdmP of the GDM biosynthetic gene cluster was involved in the formation of C-4,5 double bonds of GDM in the post-PKS tailoring process of GDM biosynthesis. The discovery of CT-1-7x from the gdmN disruption mutant of S. hygroscopicus 17997 indicated that the cytochrome P450 monooxygenase encoded by gdmP had a relaxed substrate specificity, which is common to enzymes for microbial secondary metabolite biosynthesis.
It seems that the carbamoyltransferase in the post-PKS tailoring process of GDM biosynthesis exhibited also a relaxed substrate specificity, as several GDM biosynthetic intermediates or their analogs with 7-O-carbamoylation, such as KOS-1806, reblastatin and 8-demethylgeldanamycin, were discovered or isolated.12, 13 To confirm whether CT-1-7x could be further 7-O-carbamoylated (producing GDM), a bioconversion experiment was conducted (Figure 3). Contrary to our expectation, incubation of CT-1-7x with GDM-pks−,8 a GDM's PKS gene disruption mutant of S. hygroscopicus 17997 (it lost the ability to produce GDM, but still had a full complement of post-PKS tailoring process genes), resulted in no production of GDM, while incubation of CT-1-7 (as the positive control) with GDM-pks− resulted in the production of GDM as had been reported earlier by Hong et al.6 This result led us to conclude that the carbamoyltransferase in the post-PKS tailoring process of GDM biosynthesis showed a special substrate specificity, that is, the C-4,5 of its substrate(s) being single-bonded. Therefore, 7-O-carbamoylation must take place before C-4,5 oxidation in the post-PKS tailoring process of GDM biosynthesis, but the two steps are not necessarily close to each other.
References
Stebbins, C. E. et al. Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent. Cell 89, 239–250 (1997).
Li, Y. H., Tao, P. Z., Liu, Y. Z. & Jiang, J. D. Geldanamycin, a ligand of heat shock protein 90, inhibits the replication of herpes simplex virus type 1 in vitro. Antimicrob Agents Chemother. 48, 867–872 (2004).
Rascher, A. et al. Cloning and characterization of a gene cluster for geldanamycin production in Streptomyces hygroscopicus NRRL 3602. FEMS Microbiol. Lett. 218, 223–230 (2003).
Hong, Y. S. et al. in Book of Abstracts, 13th International Symposium on the Biology of Actinomycetes (ed. Kurtboke, I.) 33 (ISBA' 13, Melbourne, Australia, 2003).
Wang, Y.G. & Gao, Q.J. Cloning of geldanamycin biosynthetic gene from Streptomyces hygroscopicus 17997. in Ninth International Symposium on the Genetics of Industrial Microorganisms, Gyeongju, Korea Abstract P2-46 (2002).
Hong, Y. S. et al. Inactivation of the carbamoyltransferase gene refines post-polyketide synthase modification steps in the biosynthesis of the antitumor agent geldanamycin. J. Am. Chem. Soc. 126, 11142–11143 (2004).
Shin, J. C. et al. Characterization of tailoring genes involved in the modification of geldanamycin polyketide in Streptomyces hygroscopicus JCM4427. J. Microbiol. Biotechnol. 18, 1101–1108 (2008).
He, W. Q., Liu, Y. Y., Sun, G. Z. & Wang, Y. G. Roles of geldanamycin biosynthetic genes in Streptomyces hygroscopicus 17997. Chin. J. Biotech. 24, 1133–1139 (2008).
Li, Y. Y., He, W. Q., Wang, Y. G., Wang, Y. C. & Shao, R. G. A new post-PKS modification process in the carbamoyltransferase gene inactivation strain of Streptomyces hygroscopicus 17997. J. Antibiot. 61, 347–355 (2008).
Liu, A. M. et al. A color reaction method for early preliminary discrimination of benzenic ansamycins [in Chinese]. Chin. J. Antibiot. 33, 403–406 (2008).
Miller, P. et al. Depletion of the erbB-2 gene product p185 by benzoquinoid ansamycins. Cancer Res. 54, 2724–2730 (1994).
Rascher, A., Hu, Z., Buchanan, G. O., Reid, R. & Hutchinson, C. R. Insights into the biosynthesis of the benzoquinone ansamycins geldanamycin and herbimycin, obtained by gene sequencing and disruption. Appl. Environ. Microbiol. 71, 4862–4871 (2005).
Buchanan, G. O. et al. Production of 8-demethylgeldanamycin and 4,5-epoxy-8-demethylgeldanamycin from a recombinant strain of Streptomyces hygroscopicus. J. Nat. Prod. 68, 607–610 (2005).
Acknowledgements
This work was supported by the National S&T Major Special Project on Major New Drug Innovation (Item Numbers 2009ZX09501-008 and 2009ZX09301-003-7-2).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Supplementary Information accompanies the paper on The Journal of Antibiotics website
Supplementary information
Rights and permissions
About this article
Cite this article
Ni, S., Wu, L., Wang, H. et al. 7-O-descarbamoyl-7-hydroxygeldanamycin, a minor component from the gdmN disruption mutant of Streptomyces hygroscopicus 17997. J Antibiot 63, 623–625 (2010). https://doi.org/10.1038/ja.2010.96
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ja.2010.96
Keywords
This article is cited by
-
Identification of 6-demethoxy-6-methylgeldanamycin and its implication of geldanamycin biosynthesis
The Journal of Antibiotics (2014)
-
17-O-demethylreblastatin, a subnormal intermediate in geldanamycin biosynthesis
The Journal of Antibiotics (2012)